Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer venous thromboembolism: results of a randomized trial (Select-D Rivaroxaban) - Young, AM; Marshall, A; Thirlwall, J (J Clin Oncol, 2018)
et al.